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Importance 
Cryptococcosis is an illness that affects a wide variety of mammals, including 
humans, with occasional cases also reported in birds, reptiles and amphibians. Two 
species, Cryptococcus neoformans and C. gattii, are responsible for most clinical 
cases. C. neoformans is an opportunistic human pathogen, and primarily affects 
people who are immunosuppressed; however, this does not seem to be the case for C. 
gattii in humans, or for either organism in animals. While C. neoformans and C. gattii 
are very common in some environments, most people and animals do not become ill 
after exposure. In a minority of cases, however, fungal infections become 
symptomatic in the respiratory tract, central nervous system (CNS) or other organs. 
Some infections are contained but not eliminated by the immune system, and can 
recur later in life. Cryptococcosis is sometimes fatal despite treatment. 
Etiology 
Cryptococcus spp. are fungi in the Division Basidiomycota. Although there are 
more than 30 species of Cryptococcus, only two organisms – C. neoformans and C. 
gattii (previously C. neoformans var. gattii) - commonly affect humans and animals. 
Other species including C. laurentii, C. albidus, C. uzbekistanensis, C. adeliensis, C. 
curvatus, C. magnus, C. humicolus, C. luteolus, C. macerans, C. flavescens and C. 
uniguttulatus have been found in clinical cases; however, this is rare. Of the latter 
group of organisms, C. laurentii and C. albidus have been described most often in 
people. 
Cryptococcus spp. are dimorphic fungi, but they mainly occur in the yeast form 
in both the host and the environment, and usually reproduce by budding. Mating 
produces the perfect (mycelial) stage of the fungus. While there is evidence that both 
C. neoformans and C. gattii can mate in the natural environment (but not inside 
animal hosts), this has not yet been observed outside the laboratory. The perfect stage 
that results from mating between C. neoformans organisms is called Filobasidiella 
neoformans. Filobasidiella bacillisporus results from mating between C. gattii. It is 
useful to know both names for these organisms: although the vast majority of clinical 
reports refer to the pathogenic species as Cryptococcus, the name Filobasidiella can 
occasionally be encountered. Some strains of C. neoformans can also mate with C. 
gattii.  
C. neoformans and C. gattii have been divided into serotypes, and also into 
“molecular” (genetic) types. There are four serotypes, A through D, based on the 
capsular antigens. C. neoformans currently contains serotypes A, D and AD, and is 
divided into two varieties: C. neoformans var. grubii (serotype A) and C. neoformans 
var. neoformans (serotype D). Serotype AD consists of hybrids between these two 
varieties. Serotypes B and C belong to C. gattii. Hybrids between C. neoformans and 
C. gattii also exist.  
Molecular types are mainly used in epidemiological studies of outbreaks. C. 
neoformans var. grubii contains types VNI and VNII, and C. neoformans var. 
neoformans is equivalent to type VNIV, while hybrids between C. neoformans var. 
grubii and C. neoformans var. neoformans are type VNIII. C. gattii contains the 
molecular types VGI, VGII, VGIII and VGIV. Molecular types are of special interest 
in connection with an ongoing C. gattii outbreak in northwestern North America. 
Researchers are working to determine whether these organisms, which are subtypes of 
VGII and have affected an unusual number of people and animals, differ from C. 
gattii in other parts of North America and in other countries. 
Species Affected 
Mammals and marsupials 
Cryptococcosis has been described in a many species of mammals and 
marsupials. This disease is relatively common in cats, and it has been described in 
other felids, especially cheetahs (Acinonyx jubatus). Clinical cases have also been 
reported in most other species of domesticated animals including dogs, ferrets, guinea 
pigs, horses, donkeys, cattle, sheep, goats, water buffalo, pigs and South American 
camelids (llamas, alpacas and vicunas). Among captive wild animals, cryptococcosis 
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has been documented in red foxes (Vulpes vulpes), mink, a 
civet, gazelles, tapirs (Tapirus spp.), collared peccaries 
(Tayassu tajacu), mouflon sheep (Ovis musimon), tree 
shrews (Tupaia tana and Tupaia minor), elephant shrews 
(Macroscelides proboscides), a striped grass mouse 
(Lemniscomys barbarus), potoroos (Potorous spp.), koalas 
(Phascolarctos cinereus), wallabies, non-human primates 
and wild marine mammals. The diversity of affected 
species suggests that most mammals and marsupials might 
be susceptible.  
Asymptomatic colonization of the nares has been 
reported in cats, dogs and koalas. Organisms have also been 
detected in the nares of horses and wild squirrels, but 
whether this was caused by colonization or environmental 
exposure is still unknown. 
Information about the host ranges of C. neoformans 
and C. gattii is still incomplete, but both organisms are 
known to affect cats, dogs, ferrets and cheetahs. Many cases 
of cryptococcosis in horses seem to be caused by C. gattii. 
This organism also infects koalas in Australia, with 
consequences ranging from asymptomatic colonization to 
severe illness. In addition, C. gattii has been found in 
clinical cases from goats, llamas, alpacas, tapirs and marine 
mammals. Other species of Cryptococcus that may 
occasionally cause illness in mammals include C. albidus 
(horses and a dog), C. magnus (cats), C. albidus (cats and a 
California sea lion, Zalophus californianus), C. laurentii 
(dog, equine fetuses) and C. flavescens (dog). 
Birds 
C. neoformans can temporarily colonize the intestinal 
tract of some avian species. It can also be found in the 
guano of asymptomatic birds, either because it was shed 
from the bird or because the droppings provided the 
nutrients for environmental organisms to proliferate. This 
organism is especially prevalent in droppings from 
columbiform birds (e.g., pigeons), but it has also been 
detected occasionally in fecal matter or cloacal swabs from 
some psittacine and passerine species, chickens, swans 
(Cygnus spp.), rheas (Rhea spp.) and raptors. C. gattii has 
also been isolated occasionally from bird droppings or 
cloacal swabs. 
Clinical cases are uncommon in birds, although 
psittacines are occasionally affected by C. neoformans var. 
grubii or C. gattii. Several cases of cryptococcosis, all 
caused by C. gattii, were described in captive North Island 
brown kiwis (Apteryx australis mantelli). Cryptococcosis 
seems to be very rare in poultry and pigeons, despite the 
exposure of pigeons to massive quantities of C. 
neoformans. 
Reptiles and amphibians 
A few cases of cryptococcosis have been described in 
reptiles, including lizards and snakes. Amphibians also 
seem to be susceptible: pulmonary cryptococcosis was 
reported in a wild toad that had been killed by a car.  
Zoonotic potential 
Humans can be affected by both C. neoformans and C. 
gattii. These organisms are thought to be acquired from the 
environment rather than from infected hosts, except under 
unusual circumstances such as accidental inoculation with 
infectious tissues. Human C. neoformans infections are 
occasionally associated with exposure to guano, especially 
that of pigeons. Cases have only rarely been linked to 
contact with droppings from pet birds. In one case, a person 
apparently acquired cryptococcosis from the feces of an 
asymptomatic pet magpie. Pet psittacines were implicated 
in rare cases in immunosuppressed persons. Many people 
with C. neoformans cryptococcosis have no history of 
direct contact with birds. 
Geographic Distribution 
C. neoformans occurs worldwide. C. neoformans var. 
grubii is much more common than C. neoformans var. 
neoformans in the environment, and it also accounts for 
most of the clinical cases. C. neoformans var. neoformans is 
reported to be most common in Europe.  
C. gattii was originally thought to be limited to tropical 
and sub-tropical areas of Australia, New Zealand, the 
Americas, Asia and Africa. However, this organism is now 
recognized to occur in temperate regions as well. An 
important North American focus is on Vancouver Island, 
British Columbia, where an unusual number of cases have 
been reported since 1999. Related organisms have been 
described, less frequently, in nearby areas of Canada and 
the U.S., and it is possible that the Vancouver Island strains 
are spreading. Sporadic clinical cases have also been 
reported from other temperate regions in North and South 
America and Asia. In Europe, C. gattii is most common in 
the Mediterranean region, but a few clinical cases have 
been described in colder areas.  
Transmission and Life Cycle 
Cryptococcus spp. are almost always acquired from 
environmental sources, mainly by inhalation. In people, 
these organisms usually replicate initially in the lungs; 
however, primary colonization might also occur in the nasal 
cavity and sinuses of some animals. Cryptococcal 
organisms occasionally enter the body through breaks in the 
skin, where they typically cause localized disease. In cattle 
with cryptococcal mastitis, they enter the mammary gland 
through the teat. Other routes (e.g., ascending infections via 
the urinary tract) have also been proposed. Latent infections 
have been reported in both humans and animals: small 
numbers of viable organisms, encapsulated in granulomas 
in the lungs or lymph nodes by the immune response, may 
later serve as foci of infection if the host becomes 
immunosuppressed. Organisms can also persist in the 
prostate gland of men. 
Direct transmission between people or animals seems 
to occur only in unusual circumstances (although infections 
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can be acquired from bird droppings). One person 
developed localized cryptococcosis after accidental self-
inoculation of blood. Person-to-person transmission has 
also been reported during solid organ transplantation. A 
recent case of possible nosocomial transmission occurred in 
an intensive care unit in Taiwan. A mechanically ventilated, 
long term patient with pulmonary carcinoma apparently 
became infected from the patient in the adjacent bed, who 
had disseminated cryptococcosis. The isolates from both 
patients were identical, but the route of transmission was 
unknown. There are no reports of person-to-person 
transmission by casual contact. 
Rare cases of possible or probable perinatal 
transmission have been documented in HIV-positive 
women, but not immunocompetent, HIV-negative women. 
Transplacental transmission was also reported in a harbor 
porpoise infected with C. gattii.  
Environmental niches and life cycles 
The life cycles and environmental niches of C. 
neoformans and C. gattii are still incompletely understood. 
Both of these organisms grow as yeasts inside the body, and 
reproduce by budding. In this setting, they form a large 
polysaccharide capsule, which is important in resisting 
phagocytosis by immune cells. In the environment, they 
usually proliferate as saprophytic yeasts, typically without a 
capsule. However, they can also transition from yeasts to a 
filamentous form, usually by mating. Filamentous forms are 
important because they can generate basidiospores, which 
are small enough to penetrate deeply into the lungs during 
inhalation. These spores, as well as desiccated yeasts 
(which can remain viable) are thought to be the infectious 
forms for people and animals. The relative importance of 
the two forms is still debated; however, the involvement of 
basidiospores suggests that the locations where cryptococci 
mate might influence the risk of becoming infected. Non-
desiccated yeasts are not thought to be important in 
establishing pulmonary infections, as they are too large to 
enter the alveoli.  
C. neoformans and C. gattii appear to occupy different 
environmental niches. C. neoformans is strongly associated 
with bird droppings. This organism can be found in fecal or 
cloacal samples from a wide variety of avian species, but 
pigeon guano is thought to be a major niche. Pigeon guano 
allows C. neoformans to proliferate extensively in the yeast 
form, especially when large accumulations of droppings are 
protected from sunlight in lofts or roosts. It also appears to 
support the mating of both C. neoformans var. grubii and C. 
neoformans var. neoformans. C. neoformans can remain 
viable for 2 years or more in fresh or desiccated pigeon 
feces. Droppings from some other birds, including parrots 
and canaries, can support the growth of Cryptococcus 
yeasts, but whether they can support mating is still 
uncertain.  
Some authors speculate that trees might also be an 
important niche for C. neoformans. This organism can mate 
on autoclaved tree bark in the laboratory, and C. 
neoformans var. neoformans has been detected in decaying 
wood in the hollows of trees, and in the soil around some 
trees. Nevertheless, it is possible that these organisms 
originate from bird droppings, and they are not maintained 
long-term on trees.  
Trees are thought to be the main reservoir for C. gattii. 
This organism occurs in decaying wood in the hollows of 
trees, and in the soil around some trees. At one time, C. 
gattii was linked mainly with eucalyptus trees; however, it 
has now been detected in more than 50 diverse tree species, 
including both angiosperms and gymnosperms. Some trees 
and soil appear to be permanently colonized, but 
colonization at other sites seems to be transient. Cutting of 
tree limbs, logging and soil disturbances can increase the 
concentration of infectious organisms in the air. Increased 
concentrations of C. gattii have also been detected in the air 
around eucalyptus trees when they bloom. C. gattii is also 
isolated occasionally from avian guano or cloacal samples, 
but unlike C. neoformans, it does not seem to be able to 
mate on pigeon guano alone.  
C. neoformans and C. gattii can also be found in other 
environments, where they may survive for prolonged 
periods. C. neoformans has been recovered from a wide 
variety of contaminated objects. For example, the first 
isolation of this organism was from peach juice. C. gattii 
has been detected in freshwater and saltwater samples, 
which may become contaminated from soil runoff. This 
organism was reported to survive in distilled water or ocean 
water at room temperature for more than a year. No viable 
cells were found after 3 months in distilled water at 4°C, 
10% NaCl at 4°C, or 15-20% NaCl at room temperature. 
Both C. neoformans and C. gattii have been associated 
occasionally with insects (e.g., a wasp nest and insect 
frass). Fomites, and environmental contamination from 
infected animals or people, might be responsible for 
disseminating infections from endemic foci (e.g., the area 
affected by C. gattii in the Pacific Northwest).  
Cryptococcus spp. that are rare pathogens, such as C. 
albidus or C. laurentii, can be found in various 
environments including soil, plants, food and avian guano. 
C. albidus is a widespread saprophyte in the soil. 
Disinfection 
C. neoformans is susceptible to 70% ethanol, 0.5% 
chlorhexidine, 1.2% sodium hypochlorite, iodophors (e.g., 
betadine), phenolic disinfectants, glutaraldehyde and 
formaldehyde. Hydrogen peroxide (3%) or a preparation 
containing 0.05% chlorhexidine were not effective in one 
study. In biofilms, only 0.5% chlorhexidine and extremely 
high concentrations of sodium hypochlorite were reported 
to be fungicidal. C. neoformans can also be killed by moist 
heat of 121°C for a minimum of 20 minutes or dry heat of 
165-170°C for 2 hours. Although ultraviolet light reduced 
the number of viable organisms in one experiment, it was 
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not considered to be fungicidal, as there was less than a 
hundred-fold decrease in the fungal load. 
Infections in Animals 
Incubation Period 
The average incubation period in animals is still 
uncertain, but some clinical cases can become apparent 
months or years after exposure. Few studies have 
investigated the onset of cryptococcosis in experimentally 
infected animals after inhalation. The median time to death 
in mice inoculated intranasally with an environmental C. 
neoformans (yeast) isolate was 34 days. Isolates from 
human clinical cases caused death sooner.  
Clinical Signs 
Cats 
In cats, cryptococcosis can be either focal or 
disseminated, affecting a single organ system or many. The 
clinical signs can begin insidiously, and may gradually 
become more severe over weeks or months. Fever may be 
absent, and if present, is often mild. Other nonspecific signs 
can include lethargy, anorexia and weight loss. Cats with 
localized infections, including those in the nasal cavity, do 
not necessarily have constitutional signs.  
Localized upper respiratory disease (unilateral or 
bilateral chronic rhinitis or sinusitis) is the most common 
form of cryptococcosis in cats. Frequently seen clinical 
signs include sneezing, snoring or snorting, dyspnea, nasal 
deformities and/ or a mucopurulent, serous or 
serosanguineous nasal discharge. Polyp-like masses 
sometimes protrude from one or both nostrils. Some cats 
also have concurrent cutaneous or subcutaneous swellings 
and nodules on the face, particularly the bridge of the nose, 
side of the face, upper lip or nostril. Some of these lesions 
may ulcerate. In addition, the submandibular lymph nodes 
are often enlarged. With time, infections involving the nasal 
cavity can spread to adjacent structures. Ulcerative or 
proliferative lesions may develop on the tongue, gingiva or 
palate. Extension to the ear can result in otitis media and 
vestibular signs. Dissemination to the retrobulbar tissues 
can result in exophthalmos and third eyelid prolapse. 
Extension to the brain is also possible.   
Lower respiratory disease can also occur in cats, 
although it is less common than upper respiratory lesions. 
Syndromes may include pneumonia, pleuritis and 
mediastinal masses. 
CNS involvement is common in cats, and both focal 
mass lesions (cryptococcomas) and cryptococcoal 
meningitis may be seen. The neurological signs can be mild 
to severe, with various presentations such as a change in 
temperament or behavior, depression, disorientation, 
vestibular signs (e.g., head tilt, circling, nystagmus), head 
pressing, ataxia, paresis or paralysis, tremors, seizures, 
abnormal pupillary responses and blindness. Meningitis 
may appear as pain over the thoracolumbar spine or pelvic 
limbs, but hyperesthesia and nuchal rigidity are uncommon. 
Deficits of cranial nerves 5 to 12 are often found. The CNS 
is sometimes involved even if there are few or no obvious 
neurological signs. In one case, the only sign was unusual 
sleepiness.  
Ocular lesions such as chorioretinitis, optic neuritis, 
panophthalmitis, retinal hemorrhages and iridocyclitis have 
been reported. There may also be small transparent focal 
retinal detachments with a minimal inflammatory response. 
Ocular lesions often accompany other syndromes, 
especially CNS disease. Some cats can become blind.  
Other organs including the bone (osteomyelitis), 
mediastinum, heart, thyroid gland, spleen, liver and urinary 
tract can also be affected. Cutaneous involvement usually 
appears as fluctuant or firm papules and nodules. Some skin 
lesions may ulcerate, but there is little or no pruritus. 
Generalized skin disease suggests disseminated 
cryptococcosis.  
Direct inoculation of organisms into the skin can 
occasionally cause solitary lesions.  
Dogs 
Frequently affected sites in the dog include both the 
respiratory tract and CNS. Signs primarily of upper 
respiratory tract involvement have been documented in 
some dogs, especially those infected with C. gattii; 
however, concurrent involvement of the lower respiratory 
tract or CNS is common in this species. Other organs that 
may be affected include the eye (e.g., granulomatous 
chorioretinitis, optic neuritis); lymph nodes; various 
internal organs such the kidneys, spleen and liver; and 
muscle, bone or other tissues. Subcutaneous masses have 
been reported, and one dog had an intussusception caused 
by an extraluminal cryptococcoma. Disseminated 
cryptococcosis is reported to be more common in dogs than 
cats. 
Ferrets 
Various presentations, similar to those in other species, 
have been seen in ferrets. Some affected ferrets had 
disseminated disease, but localized masses (e.g., on the 
nose, spine or digit) were reported in others. 
Lymphadenopathy and respiratory signs are reported to be 
common in this species. Neurological signs, meningitis and 
ocular signs (chorioretinitis, blindness) have also been 
documented. Gastrointestinal signs were prominent in one 
ferret with disseminated disease; the presenting signs 
included lethargy, weight loss, diarrhea and retching, as 
well as dyspnea. 
Ruminants 
Pulmonary infections, CNS involvement and cryptococcal 
mastitis have been reported in cattle. In outbreaks of 
mastitis, the clinical signs may include anorexia, decreased 
milk production and enlargement of the supramammary 
lymph nodes. The affected quarters are usually swollen and 
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firm. The milk may be viscid, mucoid and grayish-white, or 
it may be watery with flakes. Neurological signs were the 
presenting complaint in a bull with cryptococcal 
meningoencephalitis and a cow with isolated 
cryptococcomas. The clinical signs included gait 
abnormalities and visual impairment in both animals, as 
well as various other signs such as depression, circling, 
head pressing, anorexia and abnormal reflexes. In the bull, 
the brain was the only affected organ at necropsy.  
Pulmonary disease, mastitis and meningoencephalitis 
have been described in goats. One goat with cryptococcosis 
had an alopecic, exudative skin lesion on the head. Cases of 
mastitis, lung involvement and rhinitis have been reported 
in sheep, and mastitis has been documented in water 
buffalo.  
Camelids 
Syndromes that have been reported in camelids include 
lower respiratory disease, CNS disease and disseminated 
infections. 
Horses 
Published clinical cases in horses have described 
meningoencephalitis/ meningitis, lower respiratory disease 
or pneumonia, upper respiratory disease affecting the 
sinuses and/or nasal cavity, osteomyelitis, mass lesion in 
the intestinal tract, endometritis and abortions with mycotic 
placentitis, and disseminated disease. Obstructive growths 
in the nasal cavities and sinuses are a common presentation 
in some geographic areas. Lower respiratory disease was 
reported to be more frequent in Western Australia, where C. 
gattii is common. Cutaneous lesions were documented in a 
donkey. 
Birds 
Some psittacine birds with cryptococcosis have signs 
of an upper respiratory tract obstruction. These birds often 
have proliferative lesions, which may resemble neoplasia, 
around the beak or nares. The infection can progress to 
involve structures close to the nasal cavity, such as the 
rhamphotheca, nasopharynx, palate and sinuses. No internal 
organs, including the lower respiratory tract and CNS, were 
affected in most of these cases. However, severe invasive or 
disseminated disease affecting the lung, air sacs, CNS or 
other internal organs has been reported in a few psittacines.  
Cryptococcosis seems to be very rare in pigeons. One 
racing pigeon developed a localized subcutaneous swelling 
below the eye. Localized disease was also reported in 
another pigeon, while a third bird had widely disseminated 
lesions.  
Fatal C. gattii infections have been reported in captive 
kiwis. Extensive granulomatous pneumonia was found in 
two of these birds at necropsy, while the third had 
disseminated disease involving the heart, kidneys and 
proventriculus. 
 
Other species of Cryptococcus 
Species other than C. neoformans and C. gattii have 
rarely been reported to affect animals. C. albidus was found 
in a genital infection in one horse, and in cases of fatal 
disseminated cryptococcosis in a dog and a cat. Both C. 
albidus and bacterial pneumonia were thought to have 
contributed to the death of a California sea lion. This 
organism was also found in the eye of a horse with keratitis; 
however, several bacteria were also detected, and its 
contribution to the condition is uncertain.  
C. magnus was the causative agent in an 
immunocompetent cat that had a recurrent painful mass 
lesion of the foreleg, together with enlargement of the 
regional lymph node. Convulsions, seen in this cat during 
the early stage of treatment, suggested CNS involvement 
but resolved with continuing therapy. C. magnus was also 
isolated from the ear of a cat with otitis externa, but the 
inflammation was attributed to Aspergillus fumigatus, and 
the role of C. magnus is uncertain.  
C. laurentii was detected a dog with panniculitis and 
osteomyelitis. This organism was also found in the stomach 
of aborted equine fetuses. A subcutaneous infection with C. 
flavescens in a dog appeared as abscessed lesions on the 
muzzle, jaw and eyelid.  
Communicability 
Avian guano is an important source of C. neoformans 
in the environment. This organism proliferates especially 
well in pigeon droppings, where it might also mate and 
produce infectious spores. Both C. neoformans and C. gattii 
have been detected occasionally in droppings or cloacal 
swabs from other avian species. Short-term colonization of 
the intestinal tract seems to be possible. Canaries that were 
fed C. neoformans shed viable organisms in feces for up to 
8 days, and pigeons for as long as 36 days.  
Animals with clinical cryptococcosis are not thought to 
transmit these organisms by casual contact. Encapsulated 
yeasts found in the tissues are unlikely to be small enough 
to enter the alveoli of the respiratory tract. Nevertheless, 
infected animals can contaminate the environment with 
yeasts, which could proliferate if they find a suitable niche. 
Organisms from lesions or blood might also cause localized 
cryptococcosis if they are accidentally inoculated into 
tissues. 
There is one reported of transplacental transmission, in 
a harbor porpoise infected with C. gattii. 
Post Mortem Lesions 
The gross lesions may appear either as granulomas or 
as gelatinous masses with minimal inflammation.  
In cats, lesions can occur in any organ system. A 
viscous exudate is often found in the nasal passages and 
sinuses. Small gelatinous nodules may be scattered on the 
viscera of the abdominal and thoracic cavities. In cases with 
CNS involvement, the meninges can be congested and 
thickened. They sometimes have a cloudy, gelatinous 
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appearance, and they may be covered by a scant mucoid 
exudate. Gray, gelatinous masses (cryptococcomas) may 
also be found in the brain and spinal cord. Ocular lesions 
including chorioretinitis or panophthalmitis can be seen in 
some cats. CNS disease in cats may be associated with only 
minimal inflammation. 
Many dogs with fatal cryptococcosis have 
disseminated disease, with granulomas throughout the 
body. Pulmonary involvement is common, even in dogs 
with no signs of respiratory disease. Lesions may also be 
found on other organs including the kidneys, lymph nodes, 
spleen and liver. The CNS lesions resemble those in cats, 
with meningoencephalitis and mass lesions in the brain and 
spinal cord; however, in dogs the lesions are more often 
accompanied by granulomatous inflammation.  
Similar lesions may be seen in other species. 
Diagnostic Tests 
Cryptococcosis is usually diagnosed by detecting these 
organisms in blood, or in other samples from biopsies, 
impression smears, aspirates or swabs of affected sites. 
Nasal secretions, bronchial washings, skin exudates, CSF 
and urine are among the samples that may contain 
cryptococci. In one unusual case, organisms found in the 
feces of a dog led to a diagnostic workup for 
cryptococcosis. When diagnosing cryptococcosis in birds, 
the possibility of asymptomatic colonization must be 
considered. Organisms can also be detected occasionally in 
the nares of some healthy mammals. 
Cryptococcus spp. can sometimes be found in clinical 
samples by direct observation. C. neoformans and C. gattii 
are round to oval yeasts, surrounded by large capsules that 
stain strongly with Mayer’s mucicarmine. In an India ink 
preparation, the capsule appears as a clear halo around the 
yeast cell. Unless budding is observed, it can be confused 
with a fat droplet or other artifact. Other useful stains 
include Alcian blue, Gomori methenamine silver, colloidal 
iron, periodic acid-Schiff (PAS), Masson-Fontana silver 
stain, Gram’s stain, new methylene blue and Wright’s stain. 
Although pathogenic cryptococci are expected to form 
capsules in the body, non-encapsulated organisms were 
apparently observed in the tissues of one cat infected with 
C. magnus. Cryptococcus spp. can also be identified in the 
tissues by immunofluorescence or immunohistochemistry. 
Some species of Cryptococcus do not appear to stain well 
with certain antibodies. 
A latex cryptococcal agglutination test can detect C. 
neoformans capsular antigens in blood, CSF or urine. False 
negatives are possible in animals with localized disease. In 
the human literature, cross-reactivity (false positivity) has 
been reported occasionally with organisms in the genus 
Trichosporon and more rarely with Histoplasma, 
Penicillium marneffei (penicilliosis) and members of the 
Mucoromycotina (mucormycosis). 
A definitive diagnosis can also be obtained by culture. 
Although C. neoformans and C. gattii can form colonies on 
most media, growth is best on fungal media such as 
Sabouraud dextrose agar without cycloheximide. Colonies 
usually appear within 2 to 5 days, but growth may be 
delayed in samples with few organisms. The organism is 
identified by its appearance, ability to grow at 37°C and 
biochemical tests; by molecular methods such as DNA 
sequencing; or with commercial yeast identification 
systems. Differential media can also aid identification. Both 
C. neoformans and C. gattii produce melanin and usually 
form brown colonies on Niger (birdseed) agar. Canavanine-
glycine-bromthymol blue agar can distinguish C. gattii 
from C. neoformans. If needed for epidemiological 
analyses, genetic types can be identified by techniques such 
as multilocus sequence typing (MLST) or amplified 
fragment length polymorphism (AFLP). However, 
veterinary diagnostic laboratories may not identify 
Cryptococcus even to the species level.  
Treatment 
Cryptococcosis in animals is treated with antifungal 
drugs such as amphotericin B, flucytosine, itraconazole, 
fluconazole and ketoconazole. Flucytosine is not used 
alone, as this results in rapid development of resistance; 
instead, it is typically combined with amphotericin B. The 
choice of antifungal agent varies with the species of animal 
and drug side effects, and with the ability of the drug to 
penetrate into the affected site(s). Cost considerations can 
also be a factor, especially in larger animals. Short courses 
of anti-inflammatory drugs have been prescribed 
concurrently in certain cases, to decrease inflammation in 
critical sites such as the brain. 
Drug treatment is sometimes combined with surgical 
debulking or excision of a mass. Two upper respiratory 
tract infections in horses, which are challenging to treat, 
were apparently eliminated with such combination 
therapies.  
Prevention 
Whether there are any effective methods of preventing 
cryptococcosis is uncertain, as C. gattii and C. neoformans 
are widespread in environments such as avian feces, rotting 
wood and soil, and risk factors for illness are still poorly 
understood. Although some factors (e.g., soil disturbances) 
seem to increase the risk of cryptococcosis, clinical cases 
occur even in pets kept indoors. It should be kept in mind 
that many animals are probably exposed frequently, but do 
not become ill. 
Environmental modifications may be considered in 
certain situations. Some sources suggest that eucalyptus 
mulch should be avoided with kiwis, as C. gattii caused 
fatal cryptococcosis in several of these birds. 
Environmental modification was also used at the Antwerp 
Zoo, when cryptococcosis occurred in an indoor exhibit, 
and C. neoformans var. neoformans was detected in a tree-
trunk, tree-stumps, and decaying wood in that exhibit, but 
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not in surrounding areas. In this case, the contaminated 
objects were removed and replaced. 
Cryptococcal mastitis in cattle is usually associated 
with treatment of the mammary gland for another condition. 
Care should be taken not to contaminate syringes, cannulas 
or antibiotic preparations. The teat ends should also be 
adequately prepared before treatment.  
Morbidity and Mortality 
Mammals and marsupials  
Risk factors for cryptococcosis in animals are poorly 
understood. One study suggested a link between veterinary 
cases caused by C. gattii in Canada, and soil disturbances or 
logging with 10 km. Pathogenic Cryptococcus spp. have 
been found in the nares of a small percentage of animals. 
Studies from Vancouver Island, Canada, detected C. gattii 
in the nasal passages of 1.1% of dogs, 4.3% of cats and 
1.5% of horses. A study that followed a small number of 
asymptomatically infected or colonized dogs and cats found 
that some animals remained persistently colonized for 
months, while other seemed to clear the organism, and a 
few cats became ill. In this study, 2 of 7 nasally colonized 
cats with antigens in the blood developed clinical signs 
within 4-6 months. The remaining cats and all 5 dogs 
remained asymptomatic. Persistent colonization with 
Cryptococcus spp., as well as clinical cases, have also been 
reported in koalas. 
Clinical cases are reported more often in cats than other 
domesticated animals, but the reason for this is unknown. It 
was once thought that cats immunosuppressed by 
retroviruses were more likely to develop cryptococcosis. 
However, newer studies do not support this idea, and some 
recent reviews consider it to be doubtful. There is currently 
no evidence that immunosuppression plays a significant 
role in susceptibility in ferrets and dogs. Cryptococcosis 
seems to be uncommon in horses in many areas (although 
other factors could be responsible for the small number of 
reported cases); however, this species is affected relatively 
often by C. gattii in Western Australia. 
Although animals with cryptococcosis can be treated 
successfully, the prognosis can be guarded, particularly in 
animals with CNS disease. Relapses can also occur after 
apparent cure. The prognosis may vary with the species. 
Cats often respond well to treatment, especially when the 
brain is not involved. However, clinical cases in horses are 
often fatal. Cryptococcal mastitis in cattle is usually a mild 
condition, but some infections can cause the death of the 
cow. Cattle with this disease rarely recover spontaneously.  
Birds 
Despite the high prevalence of C. neoformans in some 
avian environments, cryptococcosis is an uncommon 
disease in birds. In pigeons, this has been attributed to their 
high body temperature, which is expected to inhibit 
replication of the organism. Why the organism remains 
confined to the upper respiratory tract in many clinically 
affected birds, but disseminates in others, is unknown. Most 
of the psittacine birds in a case series from Australia had 
localized upper respiratory disease, but published cases in 
Europe and the Americas often described disseminated 
cases. Some authors speculate that, in kiwis, dissemination 
might be related to the lower body temperature of ratites. 
Immunosuppression or the disruption of the normal 
bacterial flora by antibiotics have also been proposed as 
possible predisposing factors in some birds. 
Infections in Humans 
Incubation Period 
The incubation period for C. neoformans infections is 
uncertain, as this organism is ubiquitous and it is often 
impossible to determine when the person was exposed. 
Some clinical cases can occur months or years after 
exposure.  
The C. gattii organisms responsible for the Vancouver 
Island outbreak have a distinctive molecular type, which 
has allowed the incubation period to be determined in 
visitors to the island. Illnesses caused by this organism have 
appeared 6 weeks to 13 months after exposure, with an 
estimated median incubation period of 6-7 months. 
Clinical Signs 
The consequences of infection with C. neoformans or 
C. gattii range from asymptomatic colonization of the 
airways to respiratory signs of varying severity, or 
disseminated infections that may involve the CNS, eye, skin 
and other organs. While there seem to be some differences 
between the syndromes caused by C. neoformans and C. 
gattii, both species can affect any organ. In 
immunosuppressed hosts, C. neoformans may cause little 
inflammation, and the symptoms can be mild even with 
extensive disease. Only a small percentage of the people 
exposed to either organism become ill.  
In most patients, Cryptococus spp. enter the body via 
the respiratory tract and replicate first in the lungs. Many 
pulmonary infections are asymptomatic in both 
immunocompetent and immunosuppressed hosts, although 
lesions may be apparent on x-ray. In clinical cases, the 
signs vary from a nonspecific cough alone, to more 
significant symptoms that can include dyspnea or shortness 
of breath, pleuritic chest pain or hemoptysis. Other signs 
may include low-grade fever, weight loss, anorexia and 
malaise. Pleural effusions can occur, but are uncommon, 
and adult respiratory distress syndrome has been reported. 
Serious respiratory syndromes and progressive pulmonary 
disease are more likely to occur in immunocompromised 
patients. Many infections in healthy patients may be self-
limited. 
From the lungs, Cryptococcus spp. may spread to other 
organ systems, particularly in immunosuppressed patients. 
Respiratory symptoms can either precede or occur 
concurrently with other syndromes. Disseminated disease 
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can also be seen in individuals who had asymptomatic 
pulmonary infections.  
CNS disease is the most common form of disseminated 
cryptococcosis. The typical syndromes are subacute or 
chronic meningitis and meningoencephalitis, or mass 
lesions (cryptococcomas) in the brain. The development of 
the illness is often insidious, with initial signs such as 
headache, fatigue, drowsiness or changes in behavior. A 
persistent headache, often of several weeks’ duration, is a 
common presentation. Although some patients may have a 
fever, body temperature can also be only slightly elevated 
or normal. Neck stiffness is often minimal or absent. Other 
signs, such as abnormalities in vision, seizures, vomiting, 
impaired consciousness and paralysis, can develop with the 
progression of the disease. Cranial nerve paralysis is 
common. Cryptococcomas may cause focal signs such as 
aphasia, cerebellar syndrome or paresis, especially in 
immunocompetent patients. Elevated cerebrospinal fluid 
(CSF) pressure from cryptococcomas or chronic 
meningoencephalitis can lead to hydrocephalus and further 
neurological signs, including dementia. Other syndromes, 
such as spinal cord lesions or ischemic stroke, have also 
been seen. Untreated infections in the brain are eventually 
fatal, but the course of the disease varies between patients. 
These infections may be rapidly fatal in some 
immunocompromised individuals. 
The eye is also a common site of dissemination, 
resulting in lesions such as optic neuritis, chorioretinitis and 
endophthalmitis. Ocular signs, including vision loss, can 
also be caused by intracranial hypertension from CNS 
disease. 
Dissemination of organisms to the skin can cause a 
variety of lesions, which may mimic other diseases. 
Papules, which may ulcerate or evolve to other forms, are 
often seen initially. Other reported lesions include pustules, 
vesicles, bullae, ulcers, palpable purpura, superficial 
granulomas, plaques, subcutaneous tumor-like masses, 
cellulitis, abscesses or sinus tracts, and even rare cases of 
necrotizing fasciitis. AIDS patients may have umbilicated 
papules that resemble molluscum contagiosum. Cutaneous 
involvement often occurs concurrently with cryptococcosis 
in the brain or other organs.  
Less frequent or rare syndromes include osteomyelitis, 
septic arthritis, myocarditis, lymphadenitis, hepatitis, 
peritonitis, abdominal cryptococcomas, gastrointestinal 
involvement, renal abscesses, prostatitis, myositis, 
endocarditis and septic shock. In AIDS patients, invasion of 
the adrenal glands may cause adrenal insufficiency. 
Urogenital involvement is often asymptomatic.  
Residual deficits including visual impairment or 
persistent neurological defects can be seen in some patients 
after treatment.  
Primary cutaneous cryptococcosis 
Direct inoculation into the skin (primary cutaneous 
cryptococcosis) is an uncommon presentation, and typically 
results in a localized lesion such as a nodule, tubercle or 
abscess at the inoculation site. The lesions of primary 
cutaneous cryptococcosis sometimes regress spontaneously.  
Other Cryptococcus spp. infections 
Few infections with Cryptococcus species other than C. 
neoformans or C. gattii have been documented in the 
literature. Reported syndromes included fungemia or 
localized infections associated with medical devices such as 
indwelling catheters; as well as pulmonary infections, 
osteomyelitis, cutaneous lesions and septicemia. Several 
species of Cryptococcus can cause meningitis. A bone 
marrow infection with C. uzbekistanensis occurred in an 
elderly man with a T-cell lymphoma.  
Communicability 
Person-to-person transmission is very rare and has 
occurred only in unusual circumstances. A few cases were 
linked to transmission in transplanted tissues or organs, 
including internal organs and a cornea. A health care 
worker developed localized skin disease after accidental 
self-inoculation with contaminated blood. Possible 
nosocomial transmission was also reported in a case from 
an intensive care unit in Taiwan. In this incident, a 
mechanically ventilated, long term patient with pulmonary 
carcinoma apparently became infected from the patient in 
the adjacent bed, who had disseminated cryptococcosis. 
There are no reports of transmission during casual contact. 
Rare cases of possible or probable mother-to-child 
transmission have been seen in HIV-positive women, but 
there are no documented cases in infants born to 
immunocompetent women.  
Diagnostic Tests 
Cryptococcosis is usually diagnosed by detecting the 
organism or its antigens in blood, or in tissues and fluids 
from affected sites (e.g., cerebrospinal fluid, bronchial 
washings, urine). 
Cryptococcus spp. can sometimes be found in clinical 
samples by direct observation or culture, using methods 
such as those described under diagnostic tests for animals. 
Microscopy may detect nonviable yeasts, which appear 
intact, in the tissues for several months after treatment. 
During culture, human diagnostic laboratories do not 
always differentiate C. gattii from C. neoformans.  
A latex agglutination test (or less frequently used 
ELISA) can detect capsular antigens in blood or CSF. 
Antigens may not be found if the infection is localized to 
the lungs. False positive reactions can be seen occasionally 
with Trichosporon infections, or less frequently in cases of 
mucormycosis, penicilliosis or histoplasmosis. Antigen 
levels fall very slowly after treatment, as capsular material 
from non-viable organisms may persist in the body for a 
time. 
Other helpful tests include CT and MRI in patients 
with CNS disease, and x-rays in patients with pulmonary 
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signs. Serology to detect specific antibodies is not generally 
used in diagnosis, as healthy people are often seropositive.  
Treatment 
Cryptococcosis can be treated with various antifungal 
drugs including amphotericin B -
fluorocytosine), fluconazole and itraconazole. Standardized 
treatment recommendations have been published for 
illnesses caused by C. neoformans and C. gattii. The 
recommended drugs and duration of treatment vary with the 
site affected and the immune status of the individual. 
Supportive therapy may be needed to treat conditions such 
as dangerously elevated intracranial pressure in patients 
with CNS disease. Surgery is occasionally used to reduce 
the size of a mass lesion. Immunocompetent, asymptomatic 
patients may or may not be treated if the infection is 
confined to the lungs, as these infections are usually self-
limiting. 
There is still little experience in treating infections with 
other Cryptococcus species, but antifungal drugs were used 
successfully in some cases. Removal of any predisposing 
cause, such as an indwelling catheter, is expected to help 
the condition resolve.  
Immune reconstitution syndrome can sometimes 
complicate the treatment of cryptococcosis. This syndrome 
occurs when immunity is boosted in a patient who was 
previously immunosuppressed (e.g., a pregnant patient after 
delivery, or an HIV-infected person treated with antiviral 
drugs). The subsequent overly robust immune response to 
Cryptococcus can exacerbate the symptoms and may even 
be fatal. Concurrent anti-inflammatory medications are 
sometimes needed to treat this condition. 
After treatment, some immunosuppressed patients must 
be maintained long term or lifelong on antifungal drugs, to 
prevent latent infections from recurring.  
Prevention 
Complete prevention of exposure is probably 
impossible. C. neoformans is ubiquitous, while C. gattii has 
now been identified in a variety of climates, in and around 
many species of trees. Despite the frequency of exposure, 
most people do not become ill. 
In some circumstances, it might be possible to decrease 
the level of exposure from some environmental sources, 
such as bird droppings (especially pigeon droppings), trees 
during logging and cutting, eucalyptus trees in bloom, and 
soil disturbances. Removal of guano should be preceded by 
chemical decontamination or wetting with water or oil to 
decrease aerosolization.  
Although no cases of animal-to-human transmission 
have been reported (except via avian feces in the 
environment), it is prudent to use caution when handling 
animals with cryptococcosis. People handling such animals 
should use appropriate barrier precautions, including 
avoidance of accidental inoculation into breaks in the skin. 
Cages and litter boxes should be decontaminated regularly.  
Targeted screening of immunosuppressed individuals, 
using tests that detect cryptococcal antigens, might identify 
disseminated infections in the early stages when they are 
most readily treated. 
Morbidity and Mortality 
Cryptococcus neoformans 
In most parts of the world, C. neoformans is an 
opportunist that mainly affects people with depressed cell-
mediated immunity. AIDS patients and organ transplant 
recipients are particularly susceptible. An estimated 5-10% 
of HIV-infected persons developed cryptococcosis early in 
the AIDS epidemic; however, the incidence has decreased 
with the development of more effective retroviral therapy. 
Sarcoidosis, some forms of cancer and prolonged treatment 
with corticosteroids also increase the risk of serious illness. 
In the U.S., the annual incidence of cryptococcosis is 
currently 0.4-1.3 cases per 100,000 persons in the general 
population, 2 to 7 cases per 1,000 AIDS patients, and 0.3 to 
5.3 cases per 100 transplant patients. A few reports suggest 
that, in some locations, C. neoformans might also be an 
important pathogen of immunocompetent people. In one 
large study from China, both C. neoformans and C. gattii 
mainly affected healthy patients with no chronic conditions 
or other underlying illnesses. In Vietnam, C. neoformans 
var. grubii, rather than C. gattii was reported to be the most 
common cause of cryptococcal meningitis in 
immunocompetent people. Whether local C. neoformans 
variants or other factors might affect the pattern of illness is 
unknown.  
The outcome of a C. neoformans infection depends on 
the health of the host, the form of the disease and the 
treatment. Healthy people seem to be exposed frequently to 
this organism without becoming ill. Serological surveys 
suggest that many individuals encounter it in early 
childhood, and pulmonary granulomas containing C. 
neoformans  can be an incidental finding in people with no 
history of cryptococcosis. Symptomatic pulmonary 
infections in healthy people may resolve without treatment. 
In contrast, untreated cryptococcosis affecting the CNS is 
fatal even if the person is immunocompetent. 
The survival rate for C. neoformans cryptococcosis is 
poorer if the person is immunosuppressed or the disease is 
advanced. The 10-week case fatality rate is 10-25% among 
HIV-infected patients in developed countries, despite the 
availability of highly active antiretroviral therapy. In 
countries with limited resources, mortality in this 
population is 37–43%, even with the use of amphotericin B, 
and it can reach 100% in some case series. Case fatality 
rates of 20-100% have been reported in organ transplant 
patients.  
Cryptococcus gattii 
The incidence of illness caused by C. gattii varies 
significantly between geographic regions and populations. 
As with C. neoformans, most people exposed to C. gattii do 
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not become ill. In Australia, where this organism is 
relatively common in the environment, the average annual 
incidence of cryptococcosis caused by C. gattii is ≤ 1 case 
per million population. Aboriginal populations in Australia 
have a much higher rate of illness, with one study reporting 
up to 140 cryptococcosis cases per million population (77% 
caused by C gattii). Whether the elevated risk in this group is 
caused by increased environmental exposure, genetic 
susceptibility or other factors is still uncertain. The 
incidence of C. gattii cryptococcosis is also high in central 
Papua New Guinea (43 cases per million population), and it 
has been elevated on Vancouver Island, Canada (25 cases 
per million population) and in neighboring regions of 
Canada and the U.S. since 1999. C. gattii is uncommonly 
linked to clinical cases in most parts of North America, and 
the reason for its emergence on Vancouver Island is still 
uncertain. Some authors suggest that a localized population 
of organisms might have become more virulent and spread. 
Even on Vancouver Island, the number of clinical cases 
represents only a small fraction of the exposed population.  
Most studies report that the majority of patients 
affected by C. gattii do not have underlying illnesses and 
are not immunosuppressed. One recent analysis from the 
U.S. found that 76% of patients either smoked, were taking 
immunosuppressive medications, were infected by HIV, or 
had underlying chronic health conditions including cancer, 
various respiratory and cardiac conditions, liver disease or 
diabetes. Cigarette smoking was also identified as a risk 
factor in an Australian study. In two Australian studies, 
approximately 9% or 28% of C. gattii cases occurred in 
HIV-negative patients with other illnesses or risk factors 
including cancer, idiopathic CD4 lymphopenia or the use of 
long term immunosuppressive drugs.  
Estimates of the case fatality rates for C. gattii 
cryptococcosis in Australia, British Columbia, the U.S., and 
Papua New Guinea vary from 9% to 36%. Reported case 
fatality rates for C. gattii meningoencephalitis were 0-20% 
in Australia and 41% in Papua New Guinea. Fatal illness 
may be more likely in older patients, people with 
underlying illnesses, and those who are immunosuppressed. 
Some reports suggest that C. gattii infections might respond 
more slowly to treatment than C. neoformans.  
Other Cryptococcus species 
Clinical cases caused by organisms other than C. 
neoformans or C. gattii are rarely reported. As of 2007, 
approximately half of these cases occurred in people who 
had impaired cell-mediated immunity due to 
immunosuppressive drugs or illnesses such as cancers, and 
16% were seen in HIV-infected patients. Some cases were 
associated with invasive medical devices (e.g., indwelling 
catheters). However, illnesses have also been seen in people 
who apparently had no underlying conditions. For example, 
C. uniguttulatus meningitis occurred in a healthy, HIV-
negative man. 
Internet Resources 
Centers for Disease Control and Prevention (CDC). 
Cryptococcus neoformans 
http://www.cdc.gov/fungal/cryptococcosis-
neoformans/ 
CDC. Cryptococcus gatti 
http://www.cdc.gov/fungal/cryptococcosis-gattii/  
eMedicine.com - Cryptococcosis 
http://emedicine.medscape.com/article/215354-
overview 
eMedicine.com - Imaging in CNS Cryptococcosis 
http://emedicine.medscape.com/article/339576-
overview. 
International Veterinary Information Service (IVIS) 
http://www.ivis.org 
Material Safety Data Sheets –Canadian Laboratory 
Center for Disease Control  
http://www.phac-aspc.gc.ca/lab-bio/res/psds-ftss/index-
eng.php 
The Merck Manual 
http://www.merck.com/pubs/mmanual/ 
The Merck Veterinary Manual  
http://www.merckvetmanual.com/mvm/index.jsp 
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